SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Guidant (GDT)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Peter Dierks who wrote (176)5/4/2001 10:09:24 PM
From: D.Austin  Read Replies (1) of 235
 
buying--------- low 30's WOW wOw WoW

"We have had no contact with the FDA. We believe that we have complied with all FDA regulations and are now trying to clarify the issues with the FDA," said Steven Tragash, director of corporate communications for Guidant.

At 4 p.m. EDT Friday on the New York Stock Exchange, shares of Guidant were down $4.80, or 13%, to $33. The stock dropped suddenly when the news of the FDA probe broke just before the market close.

this is a buying opportunity thats all
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News